STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.90
−2.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.38x
- Price / sales
- 1.42x
- Price / cash flow
- -24.20x
Enterprise value
- Enterprise value
- $291.9M
- EV / sales
- 1.88x
- EV / EBITDA
- -13.73x
- EV / EBIT
- -12.77x
- Market cap
- $221.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026